Advertisement

Biogerontology

, Volume 11, Issue 5, pp 527–536 | Cite as

Frailty and muscle metabolism dysregulation in the elderly

  • W. J. Evans
  • G. Paolisso
  • A. M. Abbatecola
  • A. Corsonello
  • S. Bustacchini
  • F. Strollo
  • F. Lattanzio
SI: Frailty, Ageing and Inflammation

Abstract

The frailty syndrome is increasingly recognized by geriatricians to identify elders at an extreme risk of adverse health outcomes. The physiological changes that result in frailty are complex and up to now have been extremely difficult to characterize due to the frequent coexistence of acute and chronic illness. Frailty is characterized by an decline in the functional reserve with several alterations in diverse physiological systems, including lower energy metabolism, decreased skeletal muscle mass and quality, altered hormonal and inflammatory functions. This altered network leads to an extreme vulnerability for disease, functional dependency, hospitalization and death. One of the most important core components of the frailty syndrome is a decreased reserve in skeletal muscle functioning which is clinically characterized by a loss in muscle mass and strength (sarcopenia), in walking performance and in endurance associated with a perception of exhaustion and fatigue. There are a number of physiological changes that occur in senescent muscle tissues that have a critical effect on body metabolism. The causes of sarcopenia are multi-factorial and can include disuse, changing hormonal function, chronic diseases, inflammation, insulin resistance, and nutritional deficiencies. In this review, we will explore the dysregulation of some biological mechanisms that may contribute to the pathophysiology of the frailty syndrome through age-related changes in skeletal muscle mass and function.

Keywords

Frailty syndrome Aging Sarcopenia 

Notes

Acknowledgments

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

References

  1. Abbatecola AM, Ferrucci L, Ceda G, Russo CR, Lauretani F, Bandinelli S, Barbieri M, Valenti G, Paolisso G (2005) Insulin resistance and muscle strength in older persons. J Gerontol A Biol Sci Med Sci 60:1278–1282PubMedGoogle Scholar
  2. Albright JW, Albright JF (2000) Soluble receptors and other substances that regulate proinflammatory cytokines in young and aging humans. J Gerontol A Biol Sci Med Sci 55:20–25Google Scholar
  3. Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves P, Zeger SL, Fried LP (2006) Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol A Biol Sci Med Sci 61(3):262–266PubMedGoogle Scholar
  4. Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafe M, Olivieri F, Giovagnetti S, Franceschi C, Guralnik JM, Paolisso G (2003) Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 284(3):E481–E487PubMedGoogle Scholar
  5. Bartali B, Frongillo EA, Bandinelli S, Lauretani F, Semba RD, Fried LP, Ferrucci L (2006) Low nutrient intake is an essential component of frailty in older persons. J Gerontol A Biol Sci Med Sci 61(6):589–593PubMedGoogle Scholar
  6. Baumgartner R, Koehler K, Romero L, Garry P (1996) Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr 64:552–558PubMedGoogle Scholar
  7. Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, Wolfson C (2007) Frailty: an emerging research and clinical paradigm–issues and controversies. J Gerontol A Biol Sci Med Sci 62(7):731–737PubMedGoogle Scholar
  8. Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O’Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM (2002) Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288(18):2282–2292CrossRefPubMedGoogle Scholar
  9. Brunnsgard H, Pederson M, Pederson BK (2001) Aging and proinflammatory cytokines. Curr Opin Hematol 8:131–136CrossRefGoogle Scholar
  10. Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C, Piepoli M, Fini M, Rosano GM (2009) Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 54(10):919–927CrossRefPubMedGoogle Scholar
  11. Campbell WW, Trappe TA, Wolfe RR, Evans WJ (2001) The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle. J Gerontol A Biol Sci Med Sci 56:M373–M380PubMedGoogle Scholar
  12. Cappola AR, Bandeen-Roche K, Wand GS, Volpato S, Fried LP (2002). Association of IGF-I levels with muscle strength and mobility in older women. J Clin Endocrinol Metab. 2001;86(9):4139-46CrossRefPubMedGoogle Scholar
  13. Cappola A, Qian-Li X, Ferrucci L, Guralnik JM, Volpato S, Fried LP (2003) Insulin-like Growth Factor I and Interleukin-6 Contribute Synergistically to Disability and Mortality in Older Women. J Clin Endocrinol Metab 88:2019–2025CrossRefPubMedGoogle Scholar
  14. Carmeli E, Coleman R, Reznick AZ (2002) The biochemistry of aging muscle. Exp Gerontol 37:477–489CrossRefPubMedGoogle Scholar
  15. Corti MC, Guralnik J, Salive M, Harris T, Ferrucci L, Glynn R, Havlik R (1997) Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Annuals of Internal Medicine 126:753–760Google Scholar
  16. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. (Epub ahead of print)Google Scholar
  17. Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB, Tylavsky FA, Newman AB (2007) Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 55:769–774CrossRefPubMedGoogle Scholar
  18. Ensrud KE, Ewing SK, Taylor BC, Fink HA, Cawthon PM, Stone KL, Hillier TA, Cauley JA, Hochberg MC, Rodondi N, Tracy JK, Cummings SR (2008) Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 25 168:382–389CrossRefGoogle Scholar
  19. Erim Z, Beg MF, Burke DT, de Luca CJ (1999) Effects of aging on motor-unit control properties. J Neurophysiol 82(5):2081–2091PubMedGoogle Scholar
  20. Evans WJ (2010) Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr. Feb 17Google Scholar
  21. Ferrucci L, Penninx BW, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, Leveille SG, Fried LP, Md JM (2002) Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 50(12):1947–1954CrossRefPubMedGoogle Scholar
  22. Fiatarone MA, O’Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, Roberts SB, Kehayias JJ, Lipsitz LA, Evans WJ (1994) Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 330(25):1769–1775CrossRefPubMedGoogle Scholar
  23. Filho ST, Lourenço RA, Moreira VG (2010) Comparing indexes of frailty: the cardiovascular health study and the study of osteoporotic fractures. J Am Geriatr Soc 58(2):383–385CrossRefPubMedGoogle Scholar
  24. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging: an evoluzinary perspective on immunosenescence. Ann NY Acad Sci 908:244–254CrossRefPubMedGoogle Scholar
  25. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, Cardiovascular Health Study Collaborative Research Group (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156PubMedGoogle Scholar
  26. Fry AC, Bloomer RJ, Falvo MJ, Moore CA, Schilling BK, Weiss LW (2006) Effect of a liquid multivitamin/mineral supplement on anaerobic exercise performance. Res Sports Med 1:53–64Google Scholar
  27. García-González JJ, García-Peña C, Franco-Marina F, Gutiérrez-Robledo LM (2009) A frailty index to predict the mortality risk in a population of senior mexican adults. BMC Geriatr 9:47CrossRefPubMedGoogle Scholar
  28. Hayashi T, Kawashima S, Itoh H, Yamada N, Sone H, Watanabe H, Hattori Y, Ohrui T, Yokote K, Nomura H, Umegaki H, Iguchi A, Japan CDM Group (2009) Low HDL cholesterol is associated with the risk of stroke in elderly diabetic individuals: changes in the risk for atherosclerotic diseases at various ages. Diabetes Care 32:1221–1223CrossRefPubMedGoogle Scholar
  29. Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, Ferrara CM, Shepherd P, Fisher EC, Wolfe RR, Elahi D, Evans WJ (1993) Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 264:E855–E862PubMedGoogle Scholar
  30. Kamel H, Maas D, Duthie E (2002) Role of hormones in the pathogenesis and management of sarcopenia. Drugs Aging 19:869–877Google Scholar
  31. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR (2005) Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr 82:1065–1073PubMedGoogle Scholar
  32. Kelijam M (1991) Age-related alterations of growth hormone/insulin-like-growth-factor J axis. J Am Geriatr Soc 39:295–307Google Scholar
  33. Landi F, Russo A, Pahor M, Capoluongo E, Liperoti R, Cesari M, Bernabei R, Onder G (2008) Serum high-density lipoprotein cholesterol levels and mortality in frail, community-living elderly. Gerontology 54(2):71–78CrossRefPubMedGoogle Scholar
  34. Lazarus R, Sparrow D, Weiss ST (1997) Handgrip strength and insulin levels: cross-sectional and prospective associations in the normative aging study. Metabolism 11:1266–1269CrossRefGoogle Scholar
  35. Manolio TA, Ettinger WH, Tracy RP, Kuller LH, Borhani NO, Lynch JC, Fried LP (1993) Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study. Circulation 87:728–737PubMedGoogle Scholar
  36. McKenzie D, Bua E, McKiernan S, Cao Z, Aiken JM, Wanagat J (2002) Mitochondrial DNA deletion mutations: a causal role in sarcopenia. Eur J Biochem 269:2010–2015CrossRefPubMedGoogle Scholar
  37. Morino K, Petersen KF, Shulman GI (2006) Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55:S9–S15CrossRefPubMedGoogle Scholar
  38. Morley JE (2001) Anorexia, sarcopenia, and aging. Nutrition 17:660–663CrossRefPubMedGoogle Scholar
  39. Morley JE, Perry HM 3rd, Miller DK (2002) Editorial: something about frailty. J Gerontol A Biol Sci Med Sci 57(11):M698–M704PubMedGoogle Scholar
  40. Pekkanen J, Nissinen A, Vartiainen E, Salonen JT, Punsar S, Karvonen MJ (1994) Changes in serum cholesterol level and mortality: a 30 year follow up. Am J Epidemiol 139:155–165PubMedGoogle Scholar
  41. Porter MM, Vandervoort AA, Lexell J (1995) Aging of human muscle: structure, function and adaptability. Scand J Med Sci Sports 5(3):129–142CrossRefPubMedGoogle Scholar
  42. Raiha I, Marniemi J, Puukka P, Toikka T, Ehnholm C, Sourander L (1997) Effect of serum lipids, lipoproteins, and apolipoproteins on vascular and nonvascular mortality in the elderly. Arterioscler Thromb Vasc Biol 17(7):1224–1232PubMedGoogle Scholar
  43. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495PubMedGoogle Scholar
  44. Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K (2006) Validity and reliability of the Edmonton Frail Scale. Age Ageing 35(5):526–529CrossRefPubMedGoogle Scholar
  45. Roos MR, Rice CL, Vandervoort AA (1997) Age-related changes in motor unit function. Muscle Nerve 20(6):679–690CrossRefPubMedGoogle Scholar
  46. Roubenoff R (1997) Inflammatory and hormonal mediators of cachexia. J Nutr 127:1014S–1016SPubMedGoogle Scholar
  47. Sattler FR, Castaneda-Sceppa C, Binder EF, Schroeder ET, Wang Y, Bhasin S, Kawakubo M, Stewart Y, Yarasheski KE, Ulloor J, Colletti P, Roubenoff R, Azen SP (2009) Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab 94(6):1991–2001CrossRefPubMedGoogle Scholar
  48. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M, Health ABC Study (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64(11):1183–1189PubMedGoogle Scholar
  49. Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD (2001) Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 358(9279):351–355CrossRefPubMedGoogle Scholar
  50. Song XM, Ryder JW, Kawano Y, Chibalin AV, Krook A, Zierath JR (1999) Muscle fiber type specificity in insulin signal transduction. Am J Physiol 277:R1690–R1696PubMedGoogle Scholar
  51. Staron R, Hagerman F, Hikida R, Murrey T, Hostler D, Crilll M, Ragg K, Toma K (2000) Fiber type composition of the vastus lateralis muscle of young men and women. J Histochem Cytochem 48:623–629PubMedGoogle Scholar
  52. Studenski S, Hayes RP, Leibowitz RQ, Bode R, Lavery L, Walston J, Duncan P, Perera S (2004) Clinical Global Impression of Change in Physical Frailty: development of a measure based on clinical judgment. J Am Geriatr Soc 52(9):1560–1566CrossRefPubMedGoogle Scholar
  53. Theou O, Jones GR, Overend TJ, Kloseck M, Vandervoort AA (2008) An exploration of the association between frailty and muscle fatigue. Appl Physiol Nutr Metab 33(4):651–665CrossRefPubMedGoogle Scholar
  54. Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, Ferrando A (1995) Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 269(5 Pt 1):E820–E826PubMedGoogle Scholar
  55. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57(5):M326–M332PubMedGoogle Scholar
  56. Visser M, Deeg DJ, Lips P (2003) Longitudinal Aging Study Amsterdam Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88(12):5766–5772CrossRefPubMedGoogle Scholar
  57. Volpato S, Leveille S, Corti MC, Harris T, Guralnik J (2001a) The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc 49:1142–1147CrossRefPubMedGoogle Scholar
  58. Volpato S, Zuliani G, Guralnik JM, Palmieri E, Fellin R (2001b) The inverse association between age and cholesterol level among older patients: the role of poor health status. Gerontology 47(1):36–45CrossRefPubMedGoogle Scholar
  59. Volpi E, Sheffield-Moore M, Rasmussen BB, Wolfe RR (2001) Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. JAMA 286:1206–1212CrossRefPubMedGoogle Scholar
  60. Weindruch R (1995) Interventions based on the possibility that oxidative stress contributes to sarcopenia. J Gerontol A Biol Sci Med Sci 50:157–161PubMedGoogle Scholar
  61. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P (2007) Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 92(6):2058–2065CrossRefPubMedGoogle Scholar
  62. Xue QL, Bandeen-Roche K, Varadhan R, Zhou J, Fried LP (2008) Initial manifestations of frailty criteria and the development of frailty phenotype in the Women’s Health and Aging Study II. J Gerontol A Biol Sci Med Sci 63(9):984–990PubMedGoogle Scholar
  63. Zuliani G, Romagnoli F, Bollini C, Leoci V, Soattin L, Fellin R (1999) Low Levels of high-density lipoprotein cholesterol are a marker of disability in the elderly. Gerontology 45:317–322.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • W. J. Evans
    • 1
    • 2
  • G. Paolisso
    • 3
  • A. M. Abbatecola
    • 4
  • A. Corsonello
    • 5
  • S. Bustacchini
    • 4
  • F. Strollo
    • 6
  • F. Lattanzio
    • 4
  1. 1.GlaxoSmithKlineResearch Triangle ParkUSA
  2. 2.Division of GeriatricsDuke UniversityDurhamUSA
  3. 3.Department of Geriatric Medicine and Metabolic DiseasesSecond University of NaplesNaplesItaly
  4. 4.Scientific DirectionItalian National Research Center on Aging (I.N.R.C.A.)AnconaItaly
  5. 5.Unit of Geriatric PharmacoepidemiologyResearch Hospital of Cosenza, Italian National Research Center on Aging (I.N.R.C.A)CosenzaItaly
  6. 6.Unit of EndocrinologyResearch Hospital of Rome, Italian National Research Center on Aging (I.N.R.C.A.)RomeItaly

Personalised recommendations